Review of NGS findings in a urachal carcinoma case report and literature
New gene clues found in rare bladder cancer may guide future treatment choices.
This case report and literature review examines genomic profiling in a patient with urachal carcinoma. The authors utilized next-generation …
Scientists looked at a rare bladder cancer case and found specific gene changes that could help doctors understand how the tumor grows and p…
Radiomics from edema zone predicts progression-free survival in postoperative glioma patients
New MRI Scan Predicts Brain Tumor Return With High Accuracy
A retrospective cohort study of 89 postoperative glioma patients found that a radiomics model from the 2-cm edema zone on MRI predicted 1-ye…
A new MRI scan reads brain swelling patterns to predict if a brain tumor will grow back before symptoms appear.
Medicinal mushrooms may support immune function and tolerability in cancer patients receiving chemotherapy.
Mushrooms Might Help Your Body Fight Cancer
This narrative review examined medicinal mushrooms (Trametes versicolor, Lentinula edodes, Grifola frondosa, Ganoderma lucidum, Cordyceps sp…
Adding specific mushroom extracts to chemotherapy could help your body handle treatment better and fight cancer more effectively.
Robot-assisted radiofrequency ablation reduces blood loss and hospitalization compared to open resection for osteoid osteoma.
Tiny Robot, Big Pain Relief, Rare Risk
This retrospective cohort study evaluated 84 patients with osteoid osteoma comparing robot-assisted radiofrequency ablation (RFA) to open su…
A robot-assisted tool removes bone tumors with less blood loss and faster pain relief, though it takes longer and costs more than open surge…
MRI-derived nomogram improves high-risk LARC stratification over single-feature models in a multicenter retrospective cohort.
New MRI Tool Pinpoints Which Rectal Cancer Patients Need Intensive Treatment
This multicenter retrospective cohort study evaluated a nomogram integrating habitat heterogeneity, peritumoral (3 mm) radiomic features, an…
This new approach could spare some patients from harsh treatments while ensuring others get the aggressive care they need.
Global burden of early-onset colorectal cancer from alcohol, tobacco, and inactivity declined 1990-2021
More Young Adults Getting Colorectal Cancer — But One Risk Stands Out
This global cohort review analyzed early-onset colorectal cancer attributable to behavioral risk factors from 1990 to 2021. The overall burd…
While smoking and drinking risks drop, lack of physical activity is driving a sharp rise in colon cancer for adults under 50 worldwide.
Retrospective cohort study assesses delta-NLR and baseline NLR for prognosis in soft tissue sarcoma.
A Simple Blood Test Change Could Predict Survival in Sarcoma
This retrospective cohort study included 231 patients with soft tissue sarcoma. Main findings indicate delta-NLR possessed greater predictiv…
Watching how a blood marker changes during treatment may give sarcoma patients a clearer picture of their future.
Long-course venetoclax with hypomethylating agents in unfit AML patients shows stable efficacy and MRD prognostic value.
Frail Leukemia Patients See Better Results With New Blood Monitoring
This single-center retrospective analysis evaluated long-course venetoclax combined with hypomethylating agents in unfit AML patients. Resul…
A new look at blood tests shows how well frail leukemia patients respond to standard treatment.
Review of survey data highlights high rates of misdiagnosis and delayed diagnosis in metastatic invasive lobular breast cancer.
One in Four Metastatic Breast Cancer Patients Misdiagnosed at First Visit
This cross-sectional survey review analyzed patient-reported data from 525 individuals with invasive lobular breast cancer (ILC). The author…
One in four metastatic breast cancer patients were misdiagnosed at their first doctor visit, delaying care for a stealthy cancer that spread…
FDA Approves Itovebi (Itovebi) for Endocrine-Resistant, PIK3CA-Mutated, HR-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer
FDA approves new breast cancer drug Itovebi for a specific type of advanced cancer.
The FDA approved Itovebi in combination with palbociclib and fulvestrant for adults with endocrine-resistant, PIK3CA-mutated, HR-positive, H…
A new oral drug, Itovebi, is now FDA-approved for advanced breast cancer with a specific genetic mutation, offering another option when horm…
Relacorilant plus nab-paclitaxel improves overall survival in platinum-resistant ovarian cancer.
New Drug Combo Extends Survival for Tough Ovarian Cancer Cases
In a phase 3 randomised controlled trial of 381 patients with platinum-resistant ovarian cancer, relacorilant plus nab-paclitaxel significan…
This combination offers a new, simpler option for patients who have run out of standard treatments.
Savolitinib and durvalumab combination yields response rates of 34% to 53% in papillary renal cancer patients.
New Hope for a Tough Kidney Cancer Type
This single-arm phase II study evaluated savolitinib and durvalumab in 41 treatment-naïve or pretreated patients with papillary renal cancer…
A new drug pair breaks the shield blocking treatment for a rare kidney cancer type, offering patients a chance at longer survival after stan…